Statistics

Statistics

Total Visits

Views
Global, Phase 3 study of first-line durvalumab (MEDI4736) + tremelimumab vs standard of care platinum-based chemotherapy in advanced/metastatic NSCLC: NEPTUNE 2

Total Visits Per Month

August 2019 September 2019 October 2019 November 2019 December 2019 January 2020 February 2020
Global, Phase 3 study of first-line durvalumab (MEDI4736) + tremelimumab vs standard of care platinum-based chemotherapy in advanced/metastatic NSCLC: NEPTUNE 0 0 0 0 0 0 2

Top country views

Views

Top cities views

Views

Search DSpace



Browse

My Account

Statistics